IMMUNOCOMPROMISED
Clinical trials for IMMUNOCOMPROMISED explained in plain language.
Never miss a new study
Get alerted when new IMMUNOCOMPROMISED trials appear
Sign up with your email to follow new studies for IMMUNOCOMPROMISED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for immunocompromised patients with severe parainfluenza
Disease control Recruiting nowThis study tests an experimental drug called DAS181 in people with weakened immune systems who have a serious lung infection caused by parainfluenza virus. The goal is to see if the drug helps them breathe without extra oxygen and reduces the risk of death. About 274 participants…
Matched conditions: IMMUNOCOMPROMISED
Phase: PHASE3 • Sponsor: Ansun Biopharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New radiation treatment shows promise for skin cancer in immunocompromised patients
Disease control Recruiting nowThis study tests a new type of radiation therapy called DaRT for people with a common skin cancer (squamous cell carcinoma) who have weakened immune systems. The treatment involves placing tiny radioactive seeds directly into the tumor to kill cancer cells from the inside. Resear…
Matched conditions: IMMUNOCOMPROMISED
Phase: NA • Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Donor immune cells aim to fight virus in vulnerable patients
Disease control Recruiting nowThis early-stage trial tests whether specially grown donor T cells can safely treat adenovirus infections in people with weakened immune systems, such as cancer patients. The cells are designed to target and kill the virus. The study will check for side effects and see if the inf…
Matched conditions: IMMUNOCOMPROMISED
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC